The story of Gilgamesh has survived 4,000 years. Now it arrives on a California opera stage, partly sung in the language it was first written in.

This is a visionary and essential new work, a seminal and remarkable achievement of storytelling, music, and dance.

Gilgamesh Pharma, a clinical-stage neuroscience company developing breakthrough therapies for psychiatric and neurological disorders, today announced the successful closing of a $60 million Series A ...

This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily BioPharma Dive newsletter. AbbVie has bought a psychedelic compound from a little ...

(Reuters) -Drugmaker AbbVie is in talks to acquire privately-held mental health therapeutics company Gilgamesh Pharmaceuticals in a deal worth about $1 billion, Bloomberg News reported on Wednesday, ...

In last week’s column we considered the ancient Greek story of Deucalion and the wonderful ark, which saved the peoples of antiquity from a flood sent by the angry Olympian gods. We reflected on the ...

The Epic of Gilgamesh: It’s a tale some 4,000 years old, passed down only in an extinct writing system of wedge-shaped characters on fragments of clay tablets. And now, scholars are deciphering ...